Single CAR T infusion shows strong response in patients with high-risk smoldering multiple myeloma
Summary
A single infusion of ciltacabtagene autoleucel (Carvykti) led to a 100% minimal residual disease (MRD)-negativity rate in patients with high-risk smoldering mul...
Description
A single infusion of ciltacabtagene autoleucel (Carvykti) led to a 100% minimal residual disease (MRD)-negativity rate in patients with high-risk smoldering mul...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source